Gilead Sciences (GILD) Misses Q4 EPS by 27c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $127.88 +3.26%
EPS Growth %: -464.2%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -464.2%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.44, $0.27 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Gilead Sciences sees FY2019 revenue of $21.3-21.8 billion, versus the consensus of $21.74 billion.
- Product Gross Margin 85% - 87%
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
